Cite
HARVARD Citation
Pascoe, S. et al. (2017). Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD. Respiratory medicine. pp. 20-26. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pascoe, S. et al. (2017). Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD. Respiratory medicine. pp. 20-26. [Online].